Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Cumberland Pharmaceuticals (CPIX) over the last 3 years, with Q3 2025 value amounting to $285184.0.

  • Cumberland Pharmaceuticals' Amortizatization of Intangibles changed 0.0% to $285184.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 1627.94%. This contributed to the annual value of $1.1 million for FY2024, which is 3669.72% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $285184.0 for Q3 2025, which was down 0.0% from $285185.0 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Amortizatization of Intangibles registered a high of $296150.0 during Q2 2023, and its lowest value of $125479.0 during Q4 2023.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Amortizatization of Intangibles value was $285184.0 (recorded in 2024), while the average stood at $257344.6.
  • Data for Cumberland Pharmaceuticals' Amortizatization of Intangibles shows a peak YoY increase of 12727.71% (in 2024) and a maximum YoY decrease of 370.25% (in 2024) over the last 5 years.
  • Over the past 3 years, Cumberland Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at $125479.0 in 2023, then skyrocketed by 127.28% to $285185.0 in 2024, then decreased by 0.0% to $285184.0 in 2025.
  • Its last three reported values are $285184.0 in Q3 2025, $285185.0 for Q2 2025, and $285184.0 during Q1 2025.